Status:
COMPLETED
Cardiac and Immune Cell Function in Preeclampsia
Lead Sponsor:
Queen Mary University of London
Collaborating Sponsors:
British Heart Foundation
Barts & The London NHS Trust
Conditions:
Preeclampsia
Hypertension
Eligibility:
FEMALE
18+ years
Brief Summary
Preeclampsia is a multi-system vascular disease which affects 2-5% of pregnancies. It is also a risk factor for the development of cardiovascular disease later in life and a number of functional and s...
Detailed Description
Study design The overall aim of the clinical observational study is to determine whether the pro-inflammatory immune cell phenotype observed in women with preeclampsia (PE) can be correlated to cardi...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Singleton pregnancy
- Live fetus at 11-13 weeks of gestation
- Informed, written consent
Exclusion
- Unwilling or unable to give consent
- Pre-eclamptic women with pre-existing conditions
Key Trial Info
Start Date :
January 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 6 2024
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT04508582
Start Date
January 7 2020
End Date
March 6 2024
Last Update
March 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barts Health NHS Trust, The Royal London Hospital
London, United Kingdom, E1 1BB